Abstract
Antiglaucoma medications form the cornerstones of glaucoma management, often preferred as the first line. However, the adverse reactions associated with topical antiglaucoma medications are quite common and could be a cause for poor compliance. The adverse reactions of the topical antiglaucoma medications can either be localized to the eye and periorbital area or can be systemic. Ocular side effects can result either from the preservatives such as benzalkonium chloride or could be a side effect of the drug molecule itself. They could cause significant discomfort to the patient and hence knowing the spectrum of presentation is crucial for appropriate management. These adverse effects can be managed by employing one of the following strategies depending upon the scenario: shifting to fixed combinations to minimize a load of preservatives, using preservative-free eye drops, low-concentration eye drops, decreasing the frequency of instillation, changing the class/group of antiglaucoma medications.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call